June 19, 2013

Curie-Cancer and Sanofi cooperate in research on ovarian cancer

Preclinical program of translational research to identify new target proteins

 

Curie-Cancer and Sanofi cooperate in research on ovarian cancer
Preclinical program of translational research to identify new target proteins

Paris, France – June 19, 2013 – Sanofi (EURONEXT: SAN and NYSE: SNY) and the Curie Institute, through its Curie-Cancer partnership under the Institut Carnot label, announce today the establishment of a three-year research collaboration to identify new therapeutic targets for the development of treatments for ovarian cancer.